425: Strive CEO Comments on Semler Scientific Merger

Strive CEO Matthew Cole posted on X.com regarding the proposed business combination with Semler Scientific, Inc.

Summary

• Strive, Inc. filed a Form 425 communication related to its proposed business combination with Semler Scientific, Inc.
• The communication, posted by Strive CEO Matthew Cole on X.com, discusses the merger.
• It includes a cautionary statement regarding forward-looking statements, highlighting inherent risks and uncertainties.
• The filing outlines various risks associated with the proposed transaction, including integration challenges and potential non-realization of anticipated benefits.
• Strive intends to file a Registration Statement on Form S-4, which will include an Information Statement/Proxy Statement/Prospectus for Semler Scientific stockholders' approval.
• Investors are advised to review additional SEC filings from both companies for comprehensive information.

Sentiment

Score: 5

Explanation: The filing is neutral, primarily serving as a cautionary statement about a proposed merger, detailing forward-looking statements and a comprehensive list of associated risks rather than presenting specific positive or negative results.

Positives

• The proposed transaction is expected to yield strategic and financial benefits for the combined company.
• Anticipated cost savings and strategic gains are a potential outcome of the business combination.

Negatives

• Potential for dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
• Risk of adverse reactions from Strive's or Semler Scientific's customers.
• Potential for changes to business or employee relationships due to the announcement or completion of the proposed transaction.
• Changes in Strive's or Semler Scientific's share price before closing could be negative.

Risks

• The occurrence of any event, change, or circumstances that could lead to the termination of the merger agreement.
• The proposed transaction may not close as expected or at all if closing conditions are not met timely.
• Uncertain outcomes of any legal proceedings instituted against Strive, Semler Scientific, or the combined company.
• Anticipated benefits, including cost savings and strategic gains, may not be realized, potentially due to issues with Bitcoin treasury strategies and digital assets.
• Integration of the two companies could be more difficult, time-consuming, or costly than expected.
• The proposed transaction may be more expensive or take longer to complete than anticipated.
• Diversion of management's attention from ongoing business operations and opportunities.
• Dilution for Strive shareholders due to the issuance of additional Class A common stock.
• Potential adverse reactions from customers or changes to business/employee relationships.
• Changes in Strive's or Semler Scientific's share price before closing.
• General economic and market conditions, interest and exchange rates, monetary policy, and regulatory changes could impact results.
• Other unknown or unpredictable factors could harm the combined company's results.

Future Outlook

The outlook and expectations of Strive and Semler Scientific are focused on the proposed transaction, including its strategic and financial benefits, the expected impact on the combined company's future financial performance, the timing of the closing, and the ability to successfully integrate the businesses.

Management Comments

• Matthew Cole, Chief Executive Officer of Strive, Inc., posted a communication on X.com on September 24, 2025, in connection with Strive's proposed business combination with Semler Scientific, Inc.

Industry Context

The proposed business combination reflects a strategic move common in various industries for growth and synergy. The explicit mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' indicates a potential strategic alignment or exposure to the evolving digital asset landscape, a significant trend impacting corporate treasury management and investment strategies.

Legal Proceedings

• The outcome of any legal proceedings that may be instituted against Strive or Semler Scientific or the combined company is identified as a risk factor for the proposed transaction.

Stakeholder Impact

• Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock.
• Semler Scientific stockholders will need to approve the proposed transaction.
• Customers of both companies may have adverse reactions to the merger announcement or completion.
• Employees of both companies may experience changes to business or employment relationships.

Next Steps

• Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock to be issued in connection with the proposed transaction.
• The Registration Statement will include an Information Statement/Proxy Statement/Prospectus.
• A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
• Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available.

Key Dates

Keywords

Business Combination, Merger, Acquisition, SEC Filing, Form 425, Strive Inc, Semler Scientific Inc, Corporate Governance, Risk Management, Bitcoin Treasury, Digital Assets